| abstract |
The disclosure relates to the use of polysaccharides containing the sugar structural element N-acylglucosamine for producing haemocompatible surfaces, in addition to methods for coating surfaces in a haemocompatible manner with said polysaccharides, the latter constituting the common biosynthetic precursor substances of heparin and heparan sulphates. The disclosure also relates to coated medical products, in particular stents, which contain paclitaxel as an antiproliferative active ingredient, in addition to the use of said stents for preventing restenosis. |